Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients

Mehmet Kanbay1, Mahmut Ilker Yilmaz, Mugurel Apetrii

  • 1Department of Nephrology, Gülhane School of Medicine, Ankara, Turkey.

Insights

Magnesium is vital for kidney health and may prevent heart disease in chronic kidney disease (CKD) patients. Lower magnesium levels are linked to increased cardiovascular mortality in CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Magnesium is essential for cellular function and enzyme activity.
  • Chronic kidney disease (CKD) patients face increased cardiovascular risk.
  • The role of magnesium as a cardiovascular risk factor in CKD was previously unevaluated.

Purpose of the Study:

  • To investigate magnesium as an independent cardiovascular risk factor in CKD patients.
  • To assess the relationship between magnesium levels, endothelial function, and cardiovascular outcomes in CKD.

Main Methods:

  • A cohort of 283 CKD patients was followed for cardiovascular events.
  • Flow-mediated dilatation (FMD) and nitroglycerin-mediated dilatation were assessed using ultrasound.
  • Time-to-event analysis and Cox proportional hazards models were employed.

Main Results:

  • Higher magnesium levels correlated positively with FMD, indicating less endothelial dysfunction.
  • Magnesium and estimated glomerular filtration rate (eGFR) were strong positive predictors of FMD.
  • Low serum magnesium (<2.05 mg/dl) was associated with significantly higher cardiovascular mortality rates.

Conclusions:

  • Magnesium may be an independent predictor of cardiovascular outcomes in CKD patients.
  • This study is the first to demonstrate magnesium's role in cardiovascular risk across different stages of etiologically diagnosed CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.